Biocompatibility of Hydraulic Calcium Silicate-Based Cement MTA FlowTM on Human Dental Pulp Stem Cells In Vitro
Source abstract
Abstract
Aim: hydraulic calcium silicate-based cements (HCSCs) are widely used in endodontics for vital pulp therapy and other clinical procedures due to their favorable physicochemical and biological properties. This study evaluates the biological properties of two HCSCs—MTA Flow™ and MTA Flow™ White (in a 3:2 liquid-to-powder ratio, thick consistency)—on human dental pulp stem cells (hDPSCs). Methodology: hDPSCs were exposed to leachates from MTA Flow™, MTA Flow™ White, and ProRoot® MTA. pH changes, cytotoxicity, cell proliferation, cell morphology, and cell death (apoptosis/necrosis) were assessed in vitro. Results: MTA Flow™ White and ProRoot® MTA leachates produced a strongly alkaline pH (~10–12) compared to the negative control, whereas MTA Flow™ leachate caused a smaller pH increase (~9.4). Freshly mixed cements showed moderate cytotoxicity (around 40–60% cell viability at 100% concentration), while hardened cement leachates did not significantly affect cell viability. At 100% concentration, MTA Flow™ and MTA Flow™ White leachates significantly inhibited hDPSC proliferation and caused cell death, but at lower concentrations (≤50%) they supported cell viability and proliferation comparable to ProRoot® MTA. hDPSCs exposed to MTA Flow™ and MTA Flow™ White leachates appeared more elongated morphologically than those exposed to ProRoot® MTA. Notably, cells treated with MTA Flow™ White leachates were significantly smaller than those treated with MTA Flow™. Conclusions: MTA Flow™ and MTA Flow™ White, used in 3:2 thick consistency, demonstrated biocompatibility comparable to ProRoot® MTA in vitro. While 100% leachates showed moderate cytotoxicity, lower concentration dilutions (≤50%) supported hDPSC viability, proliferation, and morphology. These findings support their potential as safe alternatives for vital pulp therapy. Further in vivo studies and dynamic models are needed to confirm long-term biological performance.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Endodontics and Root Canal Treatments · Bone Tissue Engineering Materials · Hemostasis and retained surgical items
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Dentistry, Faculty of Medicine, Vilnius University, Zalgirio 115, LT-08217 Vilnius, Lithuania
School of Dentistry, Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, 5 Mill Pool Way, Birmingham B5 7EG, UK
Department of Biological Models, Life Science Center, Institute of Biochemistry, Vilnius University, Sauletekio al. 7, LT-10257 Vilnius, Lithuania
Funding
Vilnius University Research Project, Vilnius University, Lithuania · Vilnius University
References (92)
Show source-provided references
1. Manaspon, C., Jongwannasiri, C., Chumprasert, S., Sa-Ard-Iam, N., Mahanonda, R., Pavasant, P., Porntaveetus, T., and Osathanon, T. (2021). Human dental pulp stem cell responses to different dental pulp capping materials. BMC Oral Health, 21.10.1186/s12903-021-01544-w ↗
2. Cytotoxicity of NeoMTA Plus, ProRoot MTA and Biodentine on human dental pulp stem cells10.1016/j.jds.2020.10.009 ↗
3. Kunert, M., and Lukomska-Szymanska, M. (2020). Bio-Inductive Materials in Direct and Indirect Pulp Capping—A Review Article. Materials, 13.10.3390/ma13051204 ↗
4. Vital pulp therapy for permanent teeth with diagnosis of irreversible pulpitis: Biological basis and outcome10.1111/adj.12997 ↗
5. Present status and future directions: Hydraulic materials for endodontic use10.1111/iej.13709 ↗
6. Present status and future directions—Vital pulp treatment and pulp preservation strategies10.1111/iej.13688 ↗
7. The American Association of Endodontists AAE Position Statement on Vital Pulp Therapy10.1016/j.joen.2021.07.015 ↗
8. Efficacy of direct pulp capping for management of cariously exposed pulps in permanent teeth: A systematic review and meta-analysis10.1111/iej.13449 ↗
9. Present status and future directions—Managing perforations10.1111/iej.13748 ↗
10. The use of mineral trioxide aggregate in one-visit apexification treatment: A prospective study10.1111/j.1365-2591.2007.01214.x ↗
11. Materials used in regenerative endodontic procedures and their impact on tooth discoloration10.2334/josnusd.18-0467 ↗
12. Nie, E., Yu, J., Jiang, R., Liu, X., Li, X., Islam, R., and Alam, M.K. (2021). Effectiveness of direct pulp capping bioactive materials in dentin regeneration: A review. Materials, 14.10.3390/ma14226811 ↗
13. Periapical Tissue Responses and Cementum Regeneration with Amalgam, SuperEBA, and MTA as Root-End Filling Materials10.1097/01.don.0000148145.81366.a5 ↗
14. Mineral trioxide aggregate and other bioactive endodontic cements: An updated overview—Part II: Other clinical applications and complications10.1111/iej.12843 ↗
15. Physicochemical Properties and Biocompatibility of Various Bioceramic Root Canal Sealers: In Vitro Study10.1016/j.joen.2023.05.013 ↗
16. Calcium silicate and calcium hydroxide materials for pulp capping: Biointeractivity, porosity, solubility and bioactivity of current formulations
17. Camilleri, J. (2020). Classification of Hydraulic Cements Used in Dentistry. Front. Dent. Med., 1.10.3389/fdmed.2020.00009 ↗
18. In vitro biocompatibility and bioactivity of calcium silicate-based bioceramics in endodontics (Review)10.3892/ijmm.2021.4961 ↗
19. Pulpal regeneration after cavity preparation, with special reference to close spatio-relationships between odontoblasts and immunocompetent cells10.1002/jemt.10289 ↗
20. A review of the bioactivity of hydraulic calcium silicate cements10.1016/j.jdent.2013.12.015 ↗
21. Koutroulis, A., Kuehne, S.A., Cooper, P.R., and Camilleri, J. (2019). The role of calcium ion release on biocompatibility and antimicrobial properties of hydraulic cements. Sci. Rep., 9.10.1038/s41598-019-55288-3 ↗
22. Mechanism of bioactive molecular extraction from mineralized dentin by calcium hydroxide and tricalcium silicate cement10.1016/j.dental.2017.11.010 ↗
23. Growth factor release from dentine matrix by pulp-capping agents promotes pulp tissue repair-associated events10.1111/iej.12624 ↗
24. A critical review of the material properties guiding the clinician’s choice of root canal sealers10.1007/s00784-023-05140-w ↗
25. Calcium silicate bioactive cements: Biological perspectives and clinical applications10.1016/j.dental.2015.01.004 ↗
26. Calcium silicate-based cements: Composition, properties, and clinical applications10.1111/jicd.12195 ↗
27. Mineral Trioxide Aggregate: A Comprehensive Literature Review—Part III: Clinical Applications, Drawbacks, and Mechanism of Action10.1016/j.joen.2009.09.009 ↗
28. Effect of irrigants on the color stability, solubility, and surface characteristics of calcium-silicate based cements10.5395/rde.2022.47.e10 ↗
29. Coronal Tooth Discoloration and White Mineral Trioxide Aggregate10.1016/j.joen.2012.11.053 ↗
30. Evaluation and Comparison of Occurrence of Tooth Discoloration after the Application of Various Calcium Silicate–based Cements: An Ex Vivo Study10.1016/j.joen.2015.08.034 ↗
31. Comparison of the Potential Discoloration Effect of Bioaggregate, Biodentine, and White Mineral Trioxide Aggregate on Bovine Teeth: In Vitro Research10.1016/j.joen.2016.08.020 ↗
32. Color stability of white mineral trioxide aggregate in contact with hypochlorite solution10.1016/j.joen.2013.09.040 ↗
33. Color Changes of Teeth after Treatment with Various Mineral Trioxide Aggregate–based Materials: An Ex Vivo Study10.1016/j.joen.2015.01.019 ↗
34. The influence of the oxidation degree of bismuth oxide thin films on their optical properties
35. Chemical Modification of ProRoot MTA to Improve Handling Characteristics and Decrease Setting Time10.1016/j.joen.2007.06.012 ↗
36. The Effects of Various Additives on Setting Properties of MTA10.1016/j.joen.2005.08.006 ↗
37. Effects of calcium silicate cements on dental pulp cells: A systematic review10.1016/j.jdent.2018.08.003 ↗
38. Farrugia, C., Baca, P., Camilleri, J., and Moliz, M.T.A. (2017). Antimicrobial activity of ProRoot MTA in contact with blood. Sci. Rep., 7.10.1038/srep41359 ↗
39. Osteoinductive potential and bone-bonding ability of ProRoot MTA, MTA Plus and Biodentine in rabbit intramedullary model: Microchemical characterization and histological analysis10.1016/j.dental.2017.01.017 ↗
40. Kang, T.-Y., Choi, J.-W., Seo, K.-J., Kim, K.-M., and Kwon, J.-S. (2021). Physical, Chemical, Mechanical, and Biological Properties of Four Different Commercial Root-End Filling Materials: A Comparative Study. Materials, 14.10.3390/ma14071693 ↗
41. Direct Pulp Capping with Calcium Hydroxide, Mineral Trioxide Aggregate, and Biodentine in Permanent Young Teeth with Caries: A Randomized Clinical Trial10.1016/j.joen.2017.06.031 ↗
42. Outcomes of Direct Pulp Capping by Using Either ProRoot Mineral Trioxide Aggregate or Biodentine in Permanent Teeth with Carious Pulp Exposure in 6- to 18-Year-Old Patients: A Randomized Controlled Trial10.1016/j.joen.2017.10.012 ↗
43. Effect of particle size on calcium release and elevation of pH of endodontic cements10.1111/edt.12160 ↗
44. The effect of different chelators on the dislodgement resistance of MTA Repair HP, MTA Angelus, and MTA Flow10.1007/s10266-021-00627-y ↗
45. Role of phosphate-buffered saline on push-out bond strength of MTA FlowTM and BiodentineTM after acid challenge: An in vitro study
46. Physicochemical, antimicrobial, and biological properties of White-MTAFlow10.1007/s00784-020-03543-7 ↗
47. Biocompatibility and biomineralization assessment of mineral trioxide aggregate flow10.1007/s00784-018-2423-0 ↗
48. Innovative root-end filling materials based on calcium-silicates and calcium-phosphates10.1007/s10856-017-5847-1 ↗
49. (2021). Biological Evaluation of Medical Devices–Part 12: Sample Preparation and Reference Materials (Standard No. ISO 10993-12:2021).
50. The effect of larger than cell diameter polylactic acid surface patterns on osteogenic differentiation of rat dental pulp stem cells10.1002/jbm.a.36547 ↗
51. Cytotoxicity and biocompatibility of a new bioceramic endodontic sealer containing calcium hydroxide10.1590/1807-3107bor-2019.vol33.0042 ↗
52. Escobar-García, D.M., Medina-Rosas, M.G., González-Amaro, A.M., Méndez-González, V., Flores, H., and Pozos-Guillén, A. (2022). MTA-Based Cements: Biocompatibility and Effects on the Gene Expression of Collagen Type 1 and TGF- β 1. BioMed Res. Int., 2022.10.1155/2022/2204698 ↗
53. Bossù, M., Mancini, P., Bruni, E., Uccelletti, D., Preziosi, A., Rulli, M., Relucenti, M., Donfrancesco, O., Iaculli, F., and Di Giorgio, G. (2021). Biocompatibility and Antibiofilm Properties of Calcium Silicate-Based Cements: An In Vitro Evaluation and Report of Two Clinical Cases. Biology, 10.10.3390/biology10060470 ↗
54. Freshly-mixed and setting calcium-silicate cements stimulate human dental pulp cells10.1016/j.dental.2018.02.005 ↗
55. Bonding to caries affected dentine10.1016/j.dental.2018.05.017 ↗
56. Biocompatibility evaluation of biodentine in subcutaneous tissue of rats10.1016/j.joen.2014.02.027 ↗
57. Pedano, M.S., Li, X., Yoshihara, K., Van Landuyt, K., and Van Meerbeek, B. (2020). Cytotoxicity and bioactivity of dental pulp-capping agents towards human tooth-pulp cells: A systematic review of in-vitro studies and meta-analysis of randomized and controlled clinical trials. Materials, 13.10.3390/ma13122670 ↗
58. Cytotoxic effect of a new endodontic cement and mineral trioxide aggregate on L929 line culture
59. Biocompatibility and bioactivity of set MTA Flow compared to other calcium silicate-based cements
60. Comparison of the biological properties of ProRoot MTA, OrthoMTA, and endocem MTA cements10.1016/j.joen.2014.04.013 ↗
61. Chemical-physical Properties and Apatite-forming Ability of Mineral Trioxide Aggregate Flow10.1016/j.joen.2017.05.005 ↗
62. Comparison of Intracanal EndoSequence Root Repair Material and ProRoot MTA to Induce pH Changes in Simulated Root Resorption Defects over 4 Weeks in Matched Pairs of Human Teeth10.1016/j.joen.2011.01.010 ↗
63. In vitro biocompatibility of denture relining materials10.1111/j.1741-2358.2006.00103.x ↗
64. (2009). Biological evaluation of medical devices—Part 5: Tests for in vitro cytotoxicity (Standard No. ISO 10993-5:2009).
65. The chemical composition of mineral trioxide aggregate10.4103/0972-0707.48834 ↗
66. Cytotoxicity of Newly Developed Ortho MTA Root-end Filling Materials10.1016/j.joen.2012.09.004 ↗
67. In vivo evaluation of the inflammatory response and IL-6 immunoexpression promoted by Biodentine and MTA Angelus
68. Khandelwal, A., Janani, K., Teja, K., Jose, J., Battineni, G., Riccitiello, F., Valletta, A., Palanivelu, A., and Spagnuolo, G. (2022). Review Article Periapical Healing following Root Canal Treatment Using Different Endodontic Sealers: A Systematic Review. BioMed Res. Int., 2022.10.1155/2022/3569281 ↗
69. Rapid Apical Healing with Simple Obturation Technique in Response to a Calcium Silicate-Based Filling Material10.1155/2022/6958135 ↗
70. Biomineralization potential and biological properties of a new tantalum oxide (Ta2O5)–containing calcium silicate cement10.1007/s00784-021-04117-x ↗
71. Biocompatibility and mineralized nodule formation of Neo MTA Plus and an experimental tricalcium silicate cement containing tantalum oxide
72. Leaching and cytotoxicity of bismuth oxide in ProRoot MTA—A laboratory investigation10.1111/iej.14101 ↗
73. Chemomechanical Properties and Biocompatibility of Various Premixed Putty-type Bioactive Ceramic Cements10.1016/j.joen.2023.09.005 ↗
74. In Vitro Evaluation of ProRoot MTA, Biodentine, and MM-MTA on Human Alveolar Bone Marrow Stem Cells in Terms of Biocompatibility and Mineralization10.1016/j.joen.2015.05.012 ↗
75. Kim, Y., Lee, D., Song, D., Kim, H.-M., and Kim, S.-Y. (2020). Biocompatibility and Bioactivity of Set Direct Pulp Capping Materials on Human Dental Pulp Stem Cells. Materials, 13.10.3390/ma13183925 ↗
76. Conservative Management of Mature Permanent Teeth with Carious Pulp Exposure10.1016/j.joen.2020.06.025 ↗
77. Biocompatibility of mineral trioxide aggregate flow and biodentine10.1111/iej.12989 ↗
78. Dental discoloration caused by grey-mtaflow cement: Analysis of its physicochemical, biological and antimicrobial properties10.1590/1678-7757-2020-0269 ↗
79. Cytocompatibility of Biodentine using a three-dimensional cell culture model10.1111/iej.12485 ↗
80. Kotova, A.V., Lobov, A.A., Dombrovskaya, J.A., Sannikova, V.Y., Ryumina, N.A., Klausen, P., Shavarda, A.L., Malashicheva, A.B., and Enukashvily, N.I. (2021). Comparative Analysis of Dental Pulp and Periodontal Stem Cells: Differences in Morphology, Functionality, Osteogenic Differentiation and Proteome. Biomedicines, 9.10.3390/biomedicines9111606 ↗
81. Comparative Biological Properties and Mineralization Potential of 3 Endodontic Materials for Vital Pulp Therapy: Theracal PT, Theracal LC, and Biodentine on Human Dental Pulp Stem Cells10.1016/j.joen.2021.08.001 ↗
82. Comparative analysis of the biological effects of the endodontic bioactive cements MTA-Angelus, MTA Repair HP and NeoMTA Plus on human dental pulp stem cells
83. Effects of mineral trioxide aggregate on human dental pulp cells after pulp-capping procedures10.1016/j.joen.2010.02.013 ↗
84. Wang, X., Cai, Y., Zhang, M., Xu, J., Zhang, C., and Li, J. (2023). Effect of Biodentine on Odonto/Osteogenic Differentiation of Human Dental Pulp Stem Cells. Bioengineering, 10.10.3390/bioengineering10010012 ↗
85. Seo, D.-G., Lee, D., Kim, Y.-M., Song, D., and Kim, S.-Y. (2019). Biocompatibility and Mineralization Activity of Three Calcium Silicate-Based Root Canal Sealers Compared to Conventional Resin-Based Sealer in Human Dental Pulp Stem Cells. Materials, 12.10.3390/ma12152482 ↗
86. Mineral trioxide aggregate (MTA) solubility and porosity with different water-to-powder ratios10.1097/00004770-200312000-00007 ↗
87. One extraction tool for in vitro-in vivo extrapolation? SPME-based metabolomics of in vitro 2D, 3D, and in vivo mouse melanoma models10.1016/j.jpha.2021.03.005 ↗
88. Goldberg, M. (2014). The Dental Pulp: Biology, Pathology, and Regenerative Therapies, Springer.10.1007/978-3-642-55160-4 ↗
89. An overview of the dental pulp: Its functions and responses to injury10.1111/j.1834-7819.2007.tb00525.x ↗
90. Is non-buffered DMEM solution a suitable medium for in vitro bioactivity tests?10.1039/C4TB00187G ↗
91. Thompson, J.G., McMahon, A., and Gilliam, K.J. (2014). Unique Buffering System for Cell Culture Media and Gamete and Embryo Culture Media and Methods. (No. US20140255907A1), U.S. Patent.
92. Michl, J., Park, K.C., and Swietach, P. (2019). Evidence-based guidelines for controlling pH in mammalian live-cell culture systems. Commun. Biol., 2.10.1038/s42003-019-0393-7 ↗